Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare Conferences
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) is participating in multiple upcoming healthcare conferences. The company will host a virtual fireside chat at:
- Jefferies Virtual Healthcare Conference on June 2, 2021, at 10:30 am ET
- Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021, at 5:30 pm ET
- JMP Securities Life Science Conference on June 16, 2021, at 12:30 pm ET
Featured participants include RA Session II, Dr. Suyash Prasad, and Kamran Alam. Webcasts will be available for 60 days on their corporate website.
- None.
- None.
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivitol-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in a virtual fireside chat for the Jefferies Virtual Healthcare Conference, Goldman Sachs 42nd Annual Global Healthcare Conference, and the JMP Securities Life Science Conference.
Conferences Details:
Event: |
Jefferies Virtual Healthcare Conference |
||
Date: |
Wednesday, June 2, 2021 |
||
Time: |
10:30 am ET |
||
Format: |
Fireside chat |
||
Participants: |
RA Session II, President, Founder and CEO |
||
|
Dr. Suyash Prasad, Chief Medical Officer and Head of R&D |
||
|
Kamran Alam, Chief Financial Officer |
||
|
|
||
Event: |
Goldman Sachs 42nd Annual Global Healthcare Conference |
||
Date: |
Thursday, June 10, 2021 |
||
Time: |
5:30 pm ET |
||
Format: |
Fireside chat |
||
Participants: |
RA Session II, President, Founder and CEO |
||
|
Dr. Suyash Prasad, Chief Medical Officer and Head of R&D |
||
|
Kamran Alam, Chief Financial Officer |
||
Event: |
JMP Securities Life Science Conference |
||
Date: |
Wednesday, June 16, 2021 |
||
Time: |
12:30 pm ET |
||
Format: |
Fireside chat |
||
Participants: |
RA Session II, President, Founder and CEO |
||
|
Dr. Suyash Prasad, Chief Medical Officer and Head of R&D |
||
|
Kamran Alam, Chief Financial Officer |
Webcasts for these conferences will be available in the “Events & Media” section of the Taysha corporate website at https://ir.tayshagtx.com/news-events/events-presentations. Archived versions of the webcasts will be available on the website for 60 days.
About Taysha Gene Therapies
Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for potential new cures—with a goal of dramatically improving patients’ lives. More information is available at www.tayshagtx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210526005417/en/
FAQ
What is the schedule for Taysha Gene Therapies' participation in the Jefferies Virtual Healthcare Conference?
When will Taysha Gene Therapies present at the Goldman Sachs Healthcare Conference?
What is the date and time for the JMP Securities Life Science Conference presentation by Taysha Gene Therapies?
Who are the key participants in Taysha Gene Therapies' upcoming conferences?
Where can I find the webcasts for Taysha Gene Therapies' conference presentations?
